A new organisation will produce world-class research into cancer and heart disease in the UK capital.
Five of the United Kingdom’s world-renowned medical research centres and hospitals are coming together to create what will be Europe’s leading health research powerhouse. The intention is to deliver real improvements in health for patients in London and across the world.
Academic health science partnership
Based in the UK capital, the academic health science partnership - known as UCL Partners - will support more than 3,500 scientists, senior researchers and consultants, with a combined annual turnover of about two billion pounds.
By pooling resources and expertise, UCL Partners, which together treats more than 1.5 million patients every year, should deliver the benefits more rapidly to patients.
UCL Partners comprises:
UCL (University College London) - one of the world’s top 10 academies - and rated the best UK university for health research;
Great Ormond Street Hospital for Children National Health Service (NHS) Trust, the world-class children’s research hospital, that has the broadest range of paediatric specialists under one roof anywhere in the UK;
Moorfields Eye Hospital NHS Foundation Trust that, together with the UCL Institute of Ophthalmology, is one of the globe’s leading partnerships for eye health;
the Royal Free Hampstead NHS Trust whose clinical transplant unit is one of the most diverse in Europe;
University College London Hospitals NHS Foundation Trust that, together with UCL, forms one of the largest partnerships for biomedical research in Europe.
UCL Partners became operational during September 2008. It will focus initially on 10 areas of research, each of which poses a major health challenge; these are: the nervous system, children’s health, heart disease, transplantation, immunology, ophthalmology, deafness and hearing impairment, dental and oral disease, cancer and women’s health.
Read more here